🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Proud to have been part of this amazing team! Great collaboration between European Network of Young Gynae Oncologists and IJGC Fellows ❤️

AIOM celebra il #WorldCancerDay con l’impegno di promuovere e sensibilizzare i corretti stili di vita e l’adesione agli screening. #AIOM #CloseTheCareGap

🚨🚬🍷🍻🍟🍕🍔🚨 We can modify lifestyle & prevent/reduce cancer burden Education is key & should start in childhood Active kids w healthy habits 🛝🤾🏼‍♀️⛹️🏊🏻‍♀️⚽️🎾🏈🏓🎳🏸🏏🥏🚴🏼‍♀️⛳️🤼🥋🤺🏌️⛷️🚣🏼‍♀️🏄🏼‍♀️🏇🏻 Aktiv mot kreft Legeforeningen Oslounivsykehus IGCS ESGO OncoAlert

#LeadArticle 🚨 #Prognostic value of #ITC in #SLN in low risk #endometrial cancer by Giuseppe Cucinella Link 🖇️ bit.ly/49dUctF Mayo Clinic Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO European Network of Young Gynae Oncologists OncoAlert IJGC Fellows SoMe4GynOnc

Looking forward to attending this great Webinar with Pedro T Ramirez 🙌 Don't miss it! 💪 IJGC IJGC Fellows Houston Methodist ERAS® Society European Network of Young Gynae Oncologists

Great job, Ana Luzarraga! It was a fantastic journal club!💪🙌

Extremely proud to see the FINAL analysis of the LACC trial Journal of Clinical Oncology Worse OS at 4.5 years for #MIS Rates of carcinomatosis as recurrence 26% for MIS vs 0% for open surgery!! Houston Methodist IGCS ESGO IJGC IJGC Fellows

#UterineCancerAwarenessMonth 🌟 Uterine cancer makes up 50% of all #gyncancer cases in high-income countries 🌟 Incidence & mortality are on the rise⤴️ Pedro T Ramirez Arthur_HC_Hsu Aarthi S Jayraj Andreina Fernandes IGCS ESGO OncoAlert IJGC Fellows SoMe4GynOnc International Gyn Cancer Advocacy Network

Don’t miss it !!! 💪 Andreina Fernandes IJGC Fellows IJGC

#CervicalCancer: a new era A comprehensive discussion of: 💉 Prevention 🧬 Diagnostic 🔪 Surgery ☢️ Radiotherapy 🧪Chemotherapy 🎯Target therapy 👀 bit.ly/4cpc71G IJGC Jorge Hoegl. MD Seda Şahin Giuseppe Caruso Arthur_HC_Hsu Pedro T Ramirez Aarthi S Jayraj

Great teamwork! 💪🙌 check it out to know more about cervical cancer!

Just published online (IJGC IJGC Fellows ) our study exploring the impact of molecular classes in stage IIIC endometrial cancer patients!! Mayo OBGYN Residents & Fellows IEO Giuseppe Caruso Francesco Multinu Giuseppe Cucinella Glauco Baiocchi Giuseppe Vizzielli ijgc.bmj.com/content/early/…

💉 Prevention and screening 🔍 Diagnosis ☢️ Treatment 🧬 Novel approaches 🆓 access!! #CervicalCancer

Honored to have attended the 3M meeting(Mayo Clinic,Memorial Sloan Kettering Cancer Center, Houston Methodist MD) Inspired by global leaders in GynOnc and enjoyed connecting with friends! MSKCC Team Uterus Pedro T Ramirez Ane Gerda Z Eriksson MD PhD Pernille Bjerre Trent Mario M. Leitao, Jr IJGC Fellows Nadeem R. Abu-Rustum European Network of Young Gynae Oncologists Francesco Multinu

#InLovingMemory 🖤 It is with profound sadness, we mourn the loss of a remarkable leader in gynecologic oncology, Professor Giovanni Scambia, whose unwavering dedication, exceptional surgical expertise, and deep commitment to mentorship have left an indelible mark in our field.

Hoping to see you all there! #IJGCclub #endometrialcancer #LVSI IJGC IJGC Fellows ESGO IGCS Houston Methodist Memorial Sloan Kettering Cancer Center

The Surgical Mentorship Webinar on Vulvectomy and Reconstructive Procedures After Radical Surgery is now live on eAcademy! Watch now for expert insights and techniques.

Great job Gabriella Schivardi ! Thanks for leading this project! Enjoy the reading 📖

🎙️✨ New #IJGCpodcast!🌟 🧬 Listen to Avery Brooks, Camilla Nero & Evelyn A. Reynolds dive into the world of ctDNA in #EndometrialCancer with Pedro T Ramirez . 🔍 Biomarkers, 🩸liquid biopsy & future directions in #GynOnc 🚺 🎧 Listen now 👉 bit.ly/4laIO88

📢 New IJGC study on #EndometrialCancer with low-volume LN metastasis 🧬 📊 Largest cohort to date (N=134) 🔹 5-year RFS by molecular class:   • POLEmut: 100%   • NSMP: 84.6%   • MMRd: 65.9%   • p53abn: 76.9%   (NS; p=0.52) ⚠️ Recurrence predictors:   •